Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers

被引:1755
|
作者
Hibbard, JH
Stockard, J
Mahoney, ER
Tusler, M
机构
[1] Univ Oregon, Dept Planning Publ Policy & Management, Eugene, OR 97403 USA
[2] PeaceHlth, Survey Res & Dev, Bellevue, WA USA
关键词
patient activation; self-management; consumer roles in health care;
D O I
10.1111/j.1475-6773.2004.00269.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Controlling costs and achieving health care quality improvements require the participation of activated and informed consumers and patients. Objectives. We describe a process for conceptualizing and operationalizing what it means to be "activated" and delineate the process we used to develop a measure for assessing "activation," and the psychometric properties of that measure. Methods. We used the convergence of the findings from a national expert consensus panel and patient focus groups to define the concept and identify the domains of activation. These domains were operationalized by constructing a large item pool. Items were pilot-tested and initial psychometric analysis performed using Rasch methodology. The third stage refined and extended the measure. The fourth stage used a national probability sample to assess the measure's psychometric performance overall and within different subpopulations. Study Sample. Convenience samples of patients with and without chronic illness, and a national probability sample (N=1,515) are included at different stages in the research. Conclusions. The Patient Activation Measure is a valid, highly reliable, unidimensional, probabilistic Guttman-like scale that reflects a developmental model of activation. Activation appears to involve four stages: (1) believing the patient role is important, (2) having the confidence and knowledge necessary to take action, (3) actually taking action to maintain and improve one's health, and (4) staying the course even under stress. The measure has good psychometric properties indicating that it can be used at the individual patient level to tailor intervention and assess changes.
引用
收藏
页码:1005 / 1026
页数:22
相关论文
共 50 条
  • [1] MEASURING ACTIVATION: AN EVALUATION OF THE PATIENT ACTIVATION MEASURE (PAM)
    Chew, Sarah
    RHEUMATOLOGY, 2018, 57
  • [2] Measuring patient activation in the Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13)
    Rademakers, Jany
    Nijman, Jessica
    van der Hoek, Lucas
    Heijmans, Monique
    Rijken, Mieke
    BMC PUBLIC HEALTH, 2012, 12
  • [3] Measuring patient activation in the Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13)
    Jany Rademakers
    Jessica Nijman
    Lucas van der Hoek
    Monique Heijmans
    Mieke Rijken
    BMC Public Health, 12
  • [4] IMPACT OF PATIENT ACTIVATION MEASURE (PAM®) AND TAILORED INTERVENTIONS ON RESPIRATORY PATIENTS
    Wood, M. S.
    Belcher, J.
    Haines, J.
    Kane, B.
    THORAX, 2019, 74 : A75 - A76
  • [5] The Patient Activation Measure (PAM) and the pandemic: Predictors of patient activation among Australian health consumers during the COVID-19 pandemic
    Dammery, Genevieve
    Vitangcol, Kathryn
    Ansell, James
    Ellis, Louise A.
    Smith, Carolynn L.
    Carrigan, Ann
    Braithwaite, Jeffrey
    Zurynski, Yvonne
    HEALTH EXPECTATIONS, 2023, 26 (03) : 1107 - 1117
  • [6] Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)
    Guendalina Graffigna
    Serena Barello
    Andrea Bonanomi
    Edoardo Lozza
    Judith Hibbard
    BMC Medical Informatics and Decision Making, 15
  • [7] Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)
    Graffigna, Guendalina
    Barello, Serena
    Bonanomi, Andrea
    Lozza, Edoardo
    Hibbard, Judith
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2015, 15
  • [8] Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting
    Magdalena Holter
    Alexander Avian
    Martin Weger
    Sanja Strini
    Monja Michelitsch
    Katja Brenk-Franz
    Andreas Wedrich
    Andrea Berghold
    Quality of Life Research, 2024, 33 : 1389 - 1400
  • [9] Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting
    Holter, Magdalena
    Avian, Alexander
    Weger, Martin
    Strini, Sanja
    Michelitsch, Monja
    Brenk-Franz, Katja
    Wedrich, Andreas
    Berghold, Andrea
    QUALITY OF LIFE RESEARCH, 2024, 33 (05) : 1389 - 1400
  • [10] PATIENT ACTIVATION MEASURE (PAM) IMPROVEMENT OPTIMIZES ESRD TRANSITION
    Mulhern, Jeffrey
    Braden, Gregory
    Delbuono, Joy
    Landry, Daniel
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)